Bolt Biotherapeutics
Price & Volume
Stats
See more52W Range | $3.75-$7.19 |
Market Cap | $7.2M |
Shares Short | 16,698 |
Financials
See moreRevenue (12 Mos) | $6.4M |
Revenue Growth (YoY) | -97.9% |
Gross Profit (12 Mos) | -$17.4M |
Diluted EPS | -$16.40 |
News
See moreYahoo Finance • last month
Metastatic HER2-Positive Breast Cancer Market Expected to Surge at a CAGR of 8.3% During the Forecast Period (2026–2036) Due to Advancing Targeted Treatments | DelveInsight
Yahoo Finance • 2 months ago
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance • 5 months ago
Bolt Biotherapeutics to Participate in Upcoming March Conferences
Yahoo Finance • 9 months ago
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
About
CEO | Mr. William P. Quinn |
CFO | Mr. William P. Quinn |
Address | 900 Chesapeake Drive, Redwood City, CA, United States, 94063 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |